— Know what they know.
Not Investment Advice
Also trades as: OPK.TA (TLV) · $vol 0M · 0KCS.L (LSE) · $vol 0M

OPK NASDAQ

OPKO Health, Inc.
1W: +16.4% 1M: +4.1% 3M: +6.7% YTD: +0.8% 1Y: -3.8% 3Y: -21.0% 5Y: -65.4%
$1.27
-0.01 (-0.78%)
 
Weekly Expected Move ±5.1%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Biotechnology · Alpha Radar Buy · Power 57 · $959.0M mcap · 333M float · 0.731% daily turnover · Short 47% of daily vol

Cash Flow Trends

Operating Cash Flow
-$179M +2.7% ▲
Capital Expenditures
$12M +50.9% ▲
5Y CAGR: -18.3%
Free Cash Flow
-$191M +8.5% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$47M +47.9% ▲
Net Change in Cash
-$63M -118.0% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$30M-$328M-$189M-$53M-$226M
Depreciation & Amort.$79M$109M$105M$98M$92M
Stock-Based Comp.$14M$19M$11M$11M$11M
Change in Working Capital-$20M$43M$22M$32M-$41M
Other Non-Cash Items-$14M$138M$22M-$286M$976K
Operating Cash Flow$38M-$95M-$28M-$183M-$179M
— Investing Activities —
Capital Expenditures-$32M-$25M-$16M-$25M-$12M
Acquisitions (Net)-$6M-$2M-$5M$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$8M$115M$364K$167M$52M
Other Investing$66M$2M$3M$211M$190M
Investing Cash Flow$36M$91M-$18M$352M$230M
— Financing Activities —
Net Debt Issuance-$11M$24M-$11M$288M-$71M
Stock Repurchased$0$0$0-$90M-$47M
Dividends Paid$0$0$0$0$0
Other Financing$893K-$774K-$272K-$14M$0
Financing Cash Flow-$10M$23M-$11M$184M-$118M
Net Change in Cash$62M$18M-$57M$350M-$63M
Cash End of Period$135M$153M$96M$446M$383M
Free Cash Flow$6M-$120M-$44M-$208M-$191M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms